CClinicalTrials.gg
Not yet recruitingNCT06578013Updated Aug 29, 2024

Effect of Acupressure-Ice Message on Primary Dysmenorrhea

An interventional study of acupressure ice massage and pelvic rocking exercises in Primary Dysmenorrhea, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to female participants aged 17 Years to 25 Years. Per ClinicalTrials.gov, last updated 2024-08-29.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
17 Years to 25 Years
Sex
Female
01

Study summary

This study will be conducted to determine the effect of acupressure ice massage on primary dysmenorrhea.

Read the detailed description

Dysmenorrhea is considered the most common gynecological complaint by young women and affects approximately 60-80% of the female population. Around 8-18% of that population report intense discomfort, causing absenteeism in several daily activities while suffering pain.

Analgesics are considered the first line of treatment, but they are known for their undesirable effects such as renal, cardiovascular and gastrointestinal complications that can negatively affect patients' health. Physical therapy has alternative techniques that assist in analgesia in a practical and effective way; among them is acupressure and cryo therapy.

The effect of application of ice on the skin has a direct action on neurons and pain receptors, lowering the speed and the number of nerve impulses. This effect is due to its action on the gate control of pain mechanism, leading to the release of endorphins and enkephalins that are pain-relieving substances.

It was proved from previous studies that using ice massage on L14 or SP6 points reduce pain intensity in females suffering from PD. So, further studies are needed to investigate the effect of acupressure ice massage not only on pain intensity but also on other symptoms severity and quality of life of females suffering from PD. Therefore, this study will be conducted for this issue which will be of valuable benefits for medical service organization and increase body of knowledge of physical therapy in scientific field.

02

Conditions studied

  • Primary Dysmenorrhea

Browse trials for

03

In context

Dysmenorrhea

398 studies on the registry are indexed under Dysmenorrhea; 96 are open to participants now.

This study's planned enrollment of 50 is below the median of 60 across 333 interventional studies indexed under Dysmenorrhea.

Browse Dysmenorrhea studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Fifty adolescents' females who are clinically diagnosed as primary dysmenorrhea.
  • Their ages will be ranged from 17-25 years old.
  • Their BMI will be less than 30 kg/m².
  • All of them are virgin.
  • Their pain level will be more than 3 on visual analogue scale.
  • Having mild to moderate score on Menstrual Distress questionnaire (MDQ) ( ≥ 50).
  • Having regular menstruation for the last 6 months (every 28-30 days with no intermittent bleeding).

Exclusion criteria

Exclusion Criteria:

  • Systematic chronic diseases or any pelvic inflammatory diseases.
  • Secondary dysmenorrhea.
  • Menstrual irregularity.
  • Nerve damage resulting in loss of feeling.
  • Swelling, scar or skin infection.
  • Diabetic patients.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    acupressure ice massage + pelvic rocking exercises

    It will include 25 participants suffering from primary dysmenorrhea who will receive acupressure ice massage on SP6 and L14 acupoints, 10 minutes on each point for 20 minutes each session, 5 sessions per cycle (through the 5 days before menstruation) for 3 consecutive menstrual cycles, in addition to pelvic rocking exercises, 15 minute/session, 3 times /week, for 3 successive menstrual cycles.

    Other: acupressure ice massage · Other: pelvic rocking exercises

  • Active comparator
    pelvic rocking exercises

    It will include 25 participants suffering from primary dysmenorrhea, who will perform pelvic rocking exercises only, 15 minutes/session, 3 times /week, for 3 successive menstrual cycles.

    Other: pelvic rocking exercises

Interventions

  • Otheracupressure ice massage

    * It will be used for participants in group (A), 2 cm diameter circular ice pieces will be placed inside plastic bags and covered with a thin gauze to prevent moisture transmission and direct ice contact with the skin to apply ice massage. * Ice massage will carried out rotationally each 1 minute (30 seconds clockwise and 30 seconds counterclockwise) on L14 point for 10 minutes and on SP6 point for another 10 minutes.

  • Otherpelvic rocking exercises

    * Pelvic rocking exercise will be used for all participants in both groups (A \& B). * Each participant will be encouraged to lie down on her back on matrix with a pillow under head then bend her knees and keep her foot flat on the floor and place one hand under curve of her back and the other hand on the top of. her abdomen then tighten buttocks and abdominal muscles simultaneously. After that each participant will be encouraged to inhale and hold (1-2-3-4) then exhale and hold 4-3-2-1 then relax muscles and feel her back flat on the underneath hand. Finally, each participant will be encouraged to repeat the last two steps about 10 times each session. * The exercise will be repeated for 15times/ session, 3 times /week, for 3 successive menstrual cycles.

06

What researchers measure

Primary outcomes

  1. Pain intensity assessment

    It will be assessed for each participant in both groups (A \& B) before and after treatment, using the visual analogue scale (VAS). The VAS is usually presented as a 10 cm horizontal line on which the participants' pain intensity is represented by a point between the extremes of " no pain at all " and " worst pain imaginable ". It's simplicity, reliability and validity as well as its ratio scale properties make the VAS the optional tool for describing pain intensity.

    Time frame: 3 months

  2. Assessment of pain pressure threshold

    A pressure algometer will be used to measure pain pressure thresholds (PPTs) for all participants in both groups before and after treatment, coinciding with peak menstrual pain on the first day of menstruation. Six specific points around the umbilicus and lower back will be assessed, with each point measured twice using a 1-cm² probe applied at 30kPa/s. The areas will be cleaned with alcohol before testing. Two points will be measured 4cm bilaterally from the umbilicus, two more 4cm below these, one 4cm below the umbilicus, and one in the lumbar region at S2-S4. The mean values of these points will be used for PPT data analysis.

    Time frame: 3 months

  3. Menstrual distress questionnaire (MDQ)

    It will be used pre and post- treatment to assess the severity of symptoms of primary dysmenorrhea for all participants in both groups (A \& B). The MDQ consists of symptoms or feelings associated with menstruation. The total number of items is 47. It is a 5 point rating scale from 0-4. For each items, there is 5 options i.e. No, mild, moderate, severe and very severe. An option of (very severe) has a score of 4, (severe) has a score of 3, (moderate) has a score of 2, (mild) has a score of 1, (No) has a score of 0. It includes seven sub-scales as (pain, water retention, autonomic reactions, negative affect, impaired concentration, mood and behavioral changes, arousal control). Overall Score was interpreted as follows :\< 50 - mild , 50 to 70 - moderate and \>70 severe.

    Time frame: 3 months

07

Study locations

1 site
  • Doaa Ashraf Abd El-Ghany
    Cairo, Egypt
    • Doaa Ashraf Abd El-Ghany, B.Sc · Contact · doaaashrafabdelghany@gmail.com · 01090052117
    • Manal Ahmed El-Shafei, PhD · Contact
    • Azza Barmoud Nashed Kassab, PhD · Principal investigator
    • Mohamed Fawzy Aboeleinen, PhD · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06578013
Lead sponsor
Cairo University
Responsible party
Doaa Ashraf Abd El-Ghany (Principal Investigator, Cairo University) — Principal investigator
First posted
Aug 29, 2024
Start date
Sep 1, 2024 (estimated)
Primary completion
Dec 1, 2024 (estimated)
Completion
Dec 15, 2024 (estimated)
Last update
Aug 29, 2024

Study contacts

Doaa Ashraf Abd El-Ghany, B.Sc
Contact
doaaashrafabdelghany@gmail.com
01090052117
Manal Ahmed El-Shafei, PhD
Contact
Azza Barmoud Nashed Kassab, PhD
study chair · Professor, Cairo university

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion